We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
+12.39%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
AUM
$1.62B
AUM Growth
+$99.5M
Cap. Flow
-$24.9M
Cap. Flow %
-1.54%
Top 10 Hldgs %
17.08%
Holding
826
New
61
Increased
333
Reduced
360
Closed
60
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
D icon
301
Dominion Energy
D
$59.9B
$1.22M 0.08%
19,855
+2,076
+12% +$130K
VKI icon
302
Invesco Advantage Municipal Income Trust II
VKI
$398M
$1.22M 0.08%
141,632
+50,524
+55% +$422K
DELL icon
303
Dell
DELL
$285B
$1.21M 0.07%
30,055
+3,313
+12% +$131K
SEAT icon
304
Vivid Seats
SEAT
$84.4M
$1.2M 0.07%
8,236
+261
+3% +$40.5K
AMCR icon
305
Amcor
AMCR
$21.9B
$1.2M 0.07%
20,123
+2,047
+11% +$119K
BXMX
306
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
$1.2M 0.07%
94,665
+19,109
+25% +$246K
GPC icon
307
Genuine Parts
GPC
$18.6B
$1.2M 0.07%
6,905
-1,147
-14% -$200K
BBDC icon
308
Barings BDC
BBDC
$975M
$1.19M 0.07%
146,233
+35,751
+32% +$309K
KNSA icon
309
Kiniksa Pharmaceuticals
KNSA
$6.07B
$1.19M 0.07%
79,419
+10,041
+14% +$146K
KMI icon
310
Kinder Morgan
KMI
$70.1B
$1.18M 0.07%
65,274
+15,387
+31% +$277K
TEI
311
Templeton Emerging Markets Income Fund
TEI
$323M
$1.17M 0.07%
213,650
-6,479
-3% -$31.2K
BEN icon
312
Franklin Resources
BEN
$16.9B
$1.17M 0.07%
44,206
+11,714
+36% +$291K
LNT icon
313
Alliant Energy
LNT
$17.8B
$1.16M 0.07%
20,991
+2,597
+14% +$139K
DLTR icon
314
Dollar Tree
DLTR
$24.6B
$1.16M 0.07%
8,173
-953
-10% -$142K
YUM icon
315
Yum! Brands
YUM
$39.5B
$1.15M 0.07%
8,985
+612
+7% +$74.1K
ARCT icon
316
Arcturus Therapeutics
ARCT
$214M
$1.14M 0.07%
67,435
+7,072
+12% +$123K
DCPH
317
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1.14M 0.07%
69,405
-30,128
-30% -$490K
WM icon
318
Waste Management
WM
$90.7B
$1.11M 0.07%
7,077
+2,913
+70% +$469K
MAS icon
319
Masco
MAS
$15B
$1.09M 0.07%
23,281
+639
+3% +$30.8K
DTM icon
320
DT Midstream
DTM
$13.7B
$1.09M 0.07%
19,651
+4,835
+33% +$276K
IOVA icon
321
Iovance Biotherapeutics
IOVA
$2.94B
$1.08M 0.07%
169,506
+77,253
+84% +$603K
VMO icon
322
Invesco Municipal Opportunity Trust
VMO
$663M
$1.08M 0.07%
109,104
+47,736
+78% +$443K
HPQ icon
323
HP
HPQ
$26.6B
$1.08M 0.07%
40,093
-1,240
-3% -$34.3K
JEF icon
324
Jefferies Financial Group
JEF
$12.7B
$1.07M 0.07%
32,811
-1,665
-5% -$55.3K
NIQ
325
DELISTED
NUVEEN INTERMEDIATE DURATION QUALITY MUNICIPAL TERM FUND
NIQ
$1.06M 0.07%
85,219
+42,634
+100% +$525K

Similar funds

Hennion & Walsh Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Hennion & Walsh Asset Management held 826 positions worth $1.62B, up 6.5% from $1.52B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Hennion & Walsh Asset Management's Q4 2022 filing shows 61 new, 333 increased, 360 reduced and 60 closed positions. Its largest new stake was ConocoPhillips: 5,945 shares worth $702K. The largest sale was Global Blood Therapeutics, Inc., an estimated $8.48M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Financials and Technology.

  • Hennion & Walsh Asset Management's largest Q4 2022 buy was ConocoPhillips: 5,945 shares worth $702K.
  • Hennion & Walsh Asset Management added most to iShares Core S&P 500 ETF in Q4 2022, an estimated $7.48M increase.
  • Hennion & Walsh Asset Management's biggest Q4 2022 reduction was Nuveen Municipal Credit Income Fund, cutting an estimated $7.27M.
  • Hennion & Walsh Asset Management fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $8.48M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 17% of its $1.62B portfolio in Q4 2022.
  • Hennion & Walsh Asset Management opened 61 new positions and closed 60 in Q4 2022.
  • Hennion & Walsh Asset Management's portfolio value rose 6.5% quarter-over-quarter to $1.62B.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2022, filed 12 Jan 2023.